Abstract:Abstract Background Trastuzumab resistance followed by metastasis is a major obstacle for improving the clinical outcome of patients with advanced human epidermal growth factor receptor 2-positive (HER-2+) breast cancer. While long non-coding RNAs (lncRNAs) can modulate cell behavior, the contribution of these RNAs in trastuzumab resistance and metastasis of HER-2+ breast cancer is not well known. In this study, we sought to identify the regulatory role of lncRNA in trastuzumab resistance and accompanied Epithelial-mesenchymal Transition (EMT) process in advanced HER-2+ breast cancer. Methods Trastuzumab-resistant SKBR-3-TR and BT474-TR cell lines were established by grafting SKBR-3 and BT474 cells into mouse models and subjected to trastuzumab treatment. LncRNA microarray followed by quantitative reverse transcription PCR (qRT-PCR) was carried out to verify the differentially expressed lncRNAs. Western blotting, bioinformatics analysis, immunofluorescence assay and immunoprecipitation assays (ChIP and RIP) were performed to identify the involvement and functional interactions between H3K27 acetylation and terminal differentiation-induced non-coding RNA (TINCR) or between TINCR and its downstream genes including miR-125b , HER-2 and Snail-1 . In addition, a series of in vitro and in vivo assays were performed to assess the functions of TINCR. Results An increase in both, IC 50 value of trastuzumab and EMT was observed in the established trastuzumab-resistant cell lines. The expression level of TINCR was significantly increased in trastuzumab-resistant cells when compared with sensitive cells. Knockdown of TINCR reversed the trastuzumab resistance and the acquired EMT in these cells. TINCR was detected in the cytoplasm of breast cancer cells and could sponge miR-125b, thereby releasing HER-2 and inducing trastuzumab resistance. In addition, Snail-1 was found to be the target gene of miR-125b and overexpression of Snail-1 could reverse the suppressed migration, invasion, and EMT caused by TINCR silencing. The upregulation of TINCR in breast cancer was attributed to the CREB-binding protein (CBP)-mediated H3K27 acetylation at the promoter region of TINCR. Clinically, HER-2+ breast cancer patients with high TINCR expression levels were associated with poor response to trastuzumab therapy and shorter survival time. Conclusion TINCR could promote trastuzumab resistance and the accompanied EMT process in breast cancer. Therefore, TINCR might be a potential indicator for prognosis and a therapeutic target to enhance the clinical efficacy of trastuzumab treatment.

Down-regulation of long non-coding RNA HOTAIR sensitizes breast cancer to trastuzumab

LncRNA-HOTAIR Activates Autophagy and Promotes the Imatinib Resistance of Gastrointestinal Stromal Tumor Cells Through a Mechanism Involving the Mir-130A/ ATG2B Pathway

HOTAIR Induces EGFR-TKIs Resistance in Non-Small Cell Lung Cancer Through Epithelial-Mesenchymal Transition.

LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer

Long Non-Coding RNA HOTAIR Enhances Radioresistance in MDA-MB231 Breast Cancer Cells

LncRNA HOTAIR Enhances Breast Cancer Radioresistance Through Facilitating HSPA1A Expression Via Sequestering Mir‐449b‐5p

HOTAIR to Induce EGFR-TKIs Resistance in Non-Small Cell Lung Cancer Via Epithelial-Mesenchymal Transition.

Downregulation of Mirorna‐141 Mediates Acquired Resistance to Trastuzumab and is Associated with Poor Outcome in Breast Cancer by Upregulating the Expression of ERBB4

The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand

Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer

LncRNA HOTAIR Promotes Chemoresistance by Facilitating Epithelial to Mesenchymal Transition Through Mir-29B/pten/pi3k Signaling in Cervical Cancer

The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells

Identification of KLK10 As a Therapeutic Target to Reverse Trastuzumab Resistance in Breast Cancer.

Long Noncoding RNA HOTAIR Promotes Breast Cancer Development Through the Lncrna HOTAIR/miR-1/GOLPH3 Axis

Long non‐coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation

Lncrna HOTAIR Promotes DNA Repair and Radioresistance of Breast Cancer Via EZH2.

Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition

Correlation Between Long Non-Coding RNAs (lncrnas) H19 Expression and Trastuzumab Resistance in Breast Cancer

Knockdown of Long Non-Coding RNA HOTAIR Inhibits Proliferation and Invasiveness and Improves Radiosensitivity in Colorectal Cancer.

LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p/FZD7 axis

LncRNA HOTAIR Contributes Taxol-resistance of Hepatocellular Carcinoma Cells Via Activating AKT Phosphorylation by Down-Regulating Mir-34A